dc.contributor.author | Ebrahimi, Farnoosh | |
dc.contributor.author | Xu, Han | |
dc.contributor.author | Fuenmayor, Evert | |
dc.contributor.author | Major, Ian | |
dc.date.accessioned | 2024-02-20T10:16:28Z | |
dc.date.available | 2024-02-20T10:16:28Z | |
dc.date.copyright | 2024 | |
dc.date.issued | 2024-02-01 | |
dc.identifier.citation | Ebrahimi, F., Xu, H., Fuenmayor, E., Major, I. (2024). Tailoring drug release in bilayer tablets through droplet deposition modeling and injection molding. International Journal of Pharmaceutics.653, 123859. https://doi.org/10.1016/j.ijpharm.2024.123859 | en_US |
dc.identifier.issn | 0378-5173 | |
dc.identifier.uri | https://research.thea.ie/handle/20.500.12065/4738 | |
dc.description.abstract | This study explores the innovative production of personalized bilayer tablets, integrating two advanced
manufacturing techniques: Droplet Deposition Modeling (DDM) and Injection Molding (IM). Unlike traditional
methods limited to customizing dense bilayer medicines, our approach uses Additive Manufacturing (AM) to
effectively adjust drug release profiles. Focusing on Caffeine and Paracetamol, we found successful processing for
both DDM and IM using Caffeine formulation. The high viscosity of Paracetamol formulation posed challenges
during DDM processing. Integrating Paracetamol formulation for the over-molding process proved effective,
demonstrating IM’s versatility in handling complex formulations. Varying infill percentages in DDM tablets led to
distinct porosities affecting diverse drug release profiles in DDM-fabricated tablets. In contrast, tablets with highdensity
structures formed through the over-molding process displayed slower and more uniform release patterns.
Combining DDM and IM techniques allows for overcoming the inherent limitations of each technique independently,
enabling the production of bilayer tablets with customizable drug release profiles. The study’s results
offer promising insights into the future of personalized medicine, suggesting new pathways for the development
of customized oral dosage forms | en_US |
dc.format | PDF | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | International Journal of Pharmaceutics | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Drug delivery | en_US |
dc.subject | Oral tablets | en_US |
dc.subject | Additive manufacturing | en_US |
dc.subject | 3D printing | en_US |
dc.subject | Mass customization | en_US |
dc.subject | Personalized medicine | en_US |
dc.subject | Polypill | en_US |
dc.title | Tailoring drug release in bilayer tablets through droplet deposition modeling and injection molding | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.contributor.affiliation | Technological University of the Shannon: Midlands Midwest | en_US |
dc.contributor.sponsor | TUS President’s Fund grant | en_US |
dc.description.peerreview | yes | en_US |
dc.identifier.doi | 10.1016/j.ijpharm.2024.123859 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-2331-4876 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-4147-9965 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0001-8982-7845 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-0538-9786 | en_US |
dc.identifier.volume | 653 | en_US |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | en_US |
dc.subject.department | PRISM: Polymer, Recycling, Industrial, Sustainability and Manufacturing Institute: TUS Midlands | en_US |
dc.type.version | info:eu-repo/semantics/publishedVersion | en_US |
dc.relation.projectid | PDF2021IM | en_US |